Quick Answer
GUIDED THERAPEUTICS INC reported Operating Income of -$2.37 million for fiscal year 2025.
GUIDED THERAPEUTICS INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$2.37M | -12.5% |
| 2024 | -$2.11M | +39.0% |
| 2023 | -$3.46M | -3.7% |
| 2022 | -$3.33M | -41.1% |
| 2021 | -$2.36M | -124.5% |
| 2020 | -$1.05M | -12.3% |
| 2019 | -$937.0K | +39.5% |
| 2018 | -$1.55M | +50.4% |
| 2017 | -$3.12M | +18.3% |
| 2016 | -$3.82M | +38.7% |
| 2015 | -$6.23M | +28.2% |
| 2014 | -$8.67M | -31.2% |
| 2013 | -$6.61M | -54.3% |
| 2012 | -$4.28M | +36.6% |
| 2011 | -$6.76M | -316.8% |
| 2010 | -$1.62M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$485.0K | +13.5% | +36.4% |
| June 30, 2025 | -$763.0K | -16.5% | -84.3% |
| March 31, 2025 | -$414.0K | -15.3% | +26.2% |
| September 30, 2024 | -$561.0K | +10.0% | +14.4% |
| June 30, 2024 | -$655.0K | +56.5% | -82.5% |
| March 31, 2024 | -$359.0K | +57.4% | +42.4% |
| September 30, 2023 | -$623.0K | +49.1% | +58.6% |
| June 30, 2023 | -$1.50M | -109.9% | -78.5% |
- GUIDED THERAPEUTICS INC showed a decrease of -12.5% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, GUIDED THERAPEUTICS INC’s operating income has declined by 46.3% (from -$1.62 million to -$2.37 million).
- The most recent figure is from GUIDED THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: